• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向人乙肝表面抗原不同位点的小干扰RNA池有效抑制乙肝病毒感染。

siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection.

作者信息

Chen Yong, Mahato Ram I

机构信息

Huaian 4th People's Hospital, Jiangsu, PR China.

出版信息

J Drug Target. 2008 Feb;16(2):140-8. doi: 10.1080/10611860701878750.

DOI:10.1080/10611860701878750
PMID:18274934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2778861/
Abstract

The main objective was to determine whether a pool of small interfering RNAs (siRNAs) targeting different regions of hepatitis B virus surface antigen (HBsAg) efficiently inhibits hepatitis B virus (HBV) infection. siRNAs targeting different regions of HBsAg were transfected into HBV-producing HepG2.2.15 cells and at 72 h post-transfection, the culture medium was collected for ELISA to determine HBsAg, while total RNA was isolated from the cells for real-time PCR. Three siRNA sequences that efficiently inhibited HBV infection were converted into small hairpin RNAs (shRNAs) and then cloned into a single plasmid psiSTRIKE driven by a single U6 promoter. These shRNA expressing plasmids were tested for HBsAg gene silencing in HepG2.2.15 cells. A pool of siRNAs targeting HBsAg efficiently inhibited HBV replication and antigen expression when transfected into HepG2.2.15 cells, compared with the use of single siRNA. Similarly, the plasmid encoding three different shRNAs driven by a single U6 promoter was more effective in silencing HBsAg at DNA, mRNA and protein levels compared with the plasmid encoding single shRNA. No apoptotic change was observed in the cells when the plasmid was transfected at a dose of 0.5-2 microg/1 x 10(6) cells after complex formation with Lipofectamine LTX. Furthermore, transfection with siRNA or shRNA did not increase interferon-gamma (IFNs-gamma) release, suggesting no induction of IFN response. In conclusion, a pool of chemically synthesised siRNAs as well as the shRNA expression plasmid encoding multiple shRNAs targeting different regions of HBsAg showed high gene silencing in HepG2.2.15 cells.

摘要

主要目的是确定一组靶向乙型肝炎病毒表面抗原(HBsAg)不同区域的小干扰RNA(siRNA)是否能有效抑制乙型肝炎病毒(HBV)感染。将靶向HBsAg不同区域的siRNA转染到产生HBV的HepG2.2.15细胞中,转染后72小时,收集培养基进行ELISA以测定HBsAg,同时从细胞中分离总RNA用于实时PCR。将三个有效抑制HBV感染的siRNA序列转化为小发夹RNA(shRNA),然后克隆到由单个U6启动子驱动的单个质粒psiSTRIKE中。检测这些表达shRNA的质粒在HepG2.2.15细胞中对HBsAg基因的沉默作用。与使用单个siRNA相比,一组靶向HBsAg的siRNA转染到HepG2.2.15细胞后能有效抑制HBV复制和抗原表达。同样,与编码单个shRNA的质粒相比,由单个U6启动子驱动的编码三种不同shRNA的质粒在DNA、mRNA和蛋白质水平上对HBsAg的沉默效果更显著。当质粒与Lipofectamine LTX形成复合物后以0.5 - 2μg/1×10⁶细胞的剂量转染时,未观察到细胞凋亡变化。此外,用siRNA或shRNA转染不会增加干扰素-γ(IFN-γ)的释放,表明未诱导IFN反应。总之,一组化学合成的siRNA以及编码靶向HBsAg不同区域的多个shRNA的shRNA表达质粒在HepG2.2.15细胞中显示出高效的基因沉默作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/f09d896a7c2f/nihms157546f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/e9104a240c4f/nihms157546f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/fa4ac8b37a3a/nihms157546f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/b2857977b538/nihms157546f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/f09d896a7c2f/nihms157546f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/e9104a240c4f/nihms157546f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/fa4ac8b37a3a/nihms157546f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/b2857977b538/nihms157546f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b7/2778861/f09d896a7c2f/nihms157546f4.jpg

相似文献

1
siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection.靶向人乙肝表面抗原不同位点的小干扰RNA池有效抑制乙肝病毒感染。
J Drug Target. 2008 Feb;16(2):140-8. doi: 10.1080/10611860701878750.
2
Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.小干扰RNA组合可介导对人乙型肝炎病毒复制和抗原表达的更强抑制作用。
J Zhejiang Univ Sci B. 2005 Apr;6(4):236-41. doi: 10.1631/jzus.2005.B0236.
3
Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.靶向病毒基因和热休克同源蛋白 70 的双链 RNA 联合治疗的抗乙肝病毒疗效。
Virol J. 2012 Nov 16;9:275. doi: 10.1186/1743-422X-9-275.
4
Establishment of a screening system for selection of siRNA target sites directed against hepatitis B virus surface gene.建立针对乙型肝炎病毒表面基因的siRNA靶位点筛选系统。
Acta Biochim Biophys Sin (Shanghai). 2005 May;37(5):310-6. doi: 10.1111/j.1745-7270.2005.00049.x.
5
Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.小干扰RNA联合疗法对HepG2.2.15细胞中的乙型肝炎病毒共价闭合环状DNA具有更强的抑制作用。
Hepatogastroenterology. 2008 Nov-Dec;55(88):2178-83.
6
[Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].[靶向S基因的小干扰RNA表达质粒转染抑制肝癌细胞中乙型肝炎病毒的复制和表达]
Zhonghua Yi Xue Za Zhi. 2009 Feb 10;89(5):347-51.
7
[PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].[前C/C基因靶向RNA干扰抑制人肝癌细胞中乙型肝炎病毒的复制和表达]
Zhonghua Yi Xue Za Zhi. 2012 Mar 20;92(11):768-72.
8
Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.通过在HepG2.2.15细胞中递送双基因表达载体pHsa-miR16-siRNA抑制乙肝病毒复制
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):828-832. doi: 10.1007/s11596-017-1810-0. Epub 2017 Dec 21.
9
RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.RNA干扰抑制HepG2-N10细胞中乙型肝炎病毒基因的表达和复制。
Chin J Dig Dis. 2006;7(4):230-6. doi: 10.1111/j.1443-9573.2006.00268.x.
10
[Inhibition of hepatitis B virus replication and expression by RNA interference in vitro].[RNA干扰体外抑制乙型肝炎病毒复制及表达]
Zhonghua Yi Xue Za Zhi. 2005 Sep 14;85(35):2503-6.

引用本文的文献

1
Therapeutic Approaches of Viral Gene Silencing by Small Interfering RNA: Strategies to Prevent the Emergence of Antiviral Resistant Escape Mutants.小干扰RNA介导的病毒基因沉默治疗方法:预防抗病毒耐药逃逸突变体出现的策略
Pharmaceuticals (Basel). 2025 Jul 1;18(7):987. doi: 10.3390/ph18070987.
2
Antiviral siRNA delivered using attenuated, anthrax toxin protects cells from the cytopathic effects of Zika virus.使用减毒炭疽毒素递送的抗病毒小干扰RNA可保护细胞免受寨卡病毒的细胞病变效应影响。
Virus Genes. 2025 Jun;61(3):342-354. doi: 10.1007/s11262-025-02152-4. Epub 2025 Mar 30.
3
A Novel Approach of Antiviral Drugs Targeting Viral Genomes.一种针对病毒基因组的抗病毒药物新方法。
Microorganisms. 2022 Jul 31;10(8):1552. doi: 10.3390/microorganisms10081552.
4
Significant inhibition of re-emerged and emerging swine enteric coronavirus in vitro using the multiple shRNA expression vector.利用多短发夹 RNA 表达载体显著抑制猪肠道冠状病毒的再出现和新出现。
Antiviral Res. 2019 Jun;166:11-18. doi: 10.1016/j.antiviral.2019.03.010. Epub 2019 Mar 21.
5
A review on current status of antiviral siRNA.抗病毒 siRNA 的研究现状综述。
Rev Med Virol. 2018 Jul;28(4):e1976. doi: 10.1002/rmv.1976. Epub 2018 Apr 15.
6
VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses.VIRsiRNApred:一个用于预测靶向人类病毒的小干扰RNA(siRNA)抑制效果的网络服务器。
J Transl Med. 2013 Dec 11;11:305. doi: 10.1186/1479-5876-11-305.
7
VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA.VIRsiRNAdb:一个经过精心整理的实验验证的病毒 siRNA/shRNA 数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D230-6. doi: 10.1093/nar/gkr1147. Epub 2011 Dec 1.
8
RNA interference for improving the outcome of islet transplantation.利用 RNA 干扰技术改善胰岛移植的效果。
Adv Drug Deliv Rev. 2011 Jan-Feb;63(1-2):47-68. doi: 10.1016/j.addr.2010.11.003. Epub 2010 Dec 13.
9
Bipartite vectors for co-expression of a growth factor cDNA and short hairpin RNA against an apoptotic gene.用于共表达生长因子cDNA和针对凋亡基因的短发夹RNA的双元载体。
J Gene Med. 2009 Sep;11(9):764-71. doi: 10.1002/jgm.1357.
10
TGF-beta1 gene silencing for treating liver fibrosis.转化生长因子-β1基因沉默治疗肝纤维化
Mol Pharm. 2009 May-Jun;6(3):772-9. doi: 10.1021/mp9000469.

本文引用的文献

1
Effect of iNOS and NF-kappaB gene silencing on beta-cell survival and function.诱导型一氧化氮合酶和核因子κB基因沉默对β细胞存活和功能的影响。
J Drug Target. 2007 Jun;15(5):358-69. doi: 10.1080/10611860701349695.
2
Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA.利用表达的长链发夹RNA在体外和体内对乙肝病毒复制进行特异性抑制。
Mol Ther. 2007 Mar;15(3):534-41. doi: 10.1038/sj.mt.6300077. Epub 2007 Jan 9.
3
Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro.shRNA在人CD34+祖细胞中的稳定表达可避免体外对siRNA诱导干扰素反应。
Nat Biotechnol. 2006 May;24(5):566-71. doi: 10.1038/nbt1206. Epub 2006 Apr 30.
4
Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties.各种RNAi构建体对乙型肝炎病毒复制的抑制作用及其药效学特性。
J Gen Virol. 2005 Dec;86(Pt 12):3227-3234. doi: 10.1099/vir.0.81171-0.
5
Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference.RNA干扰对乙型肝炎病毒表面抗原表达的治疗性抑制作用
Biochem Biophys Res Commun. 2005 Oct 28;336(3):820-30. doi: 10.1016/j.bbrc.2005.08.173.
6
Silencing gene expression with Dicer-generated siRNA pools.使用Dicer酶产生的小干扰RNA(siRNA)池使基因表达沉默。
Methods Mol Biol. 2005;309:93-196. doi: 10.1385/1-59259-935-4:093.
7
Dicers at RISC; the mechanism of RNAi.RISC中的Dicer;RNA干扰机制。
Cell. 2004 Apr 2;117(1):1-3. doi: 10.1016/s0092-8674(04)00293-4.
8
Small interfering RNA inhibits hepatitis B virus replication in mice.小干扰RNA抑制小鼠体内乙型肝炎病毒的复制。
Mol Ther. 2003 Nov;8(5):769-76. doi: 10.1016/s1525-0016(03)00244-2.
9
Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.在稳定产生乙肝病毒的细胞系中,小干扰RNA对乙肝病毒复制的抑制作用
Hepatology. 2003 Oct;38(4):842-50. doi: 10.1053/jhep.2003.50416.
10
Gene silencing in mammalian cells by PCR-based short hairpin RNA.基于聚合酶链反应的短发夹RNA介导的哺乳动物细胞基因沉默
FEBS Lett. 2003 Jul 31;548(1-3):113-8. doi: 10.1016/s0014-5793(03)00630-6.